EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access · CC BY 4.0

Non‐invasive vagus nerve stimulation to reduce ileus after colorectal surgery: randomized feasibility trial and efficacy assessment ( IDEAL Stage 2B )

Stephen J Chapman iD, Mikolaj Kowal, Jack A Helliwell, Sonia Lockwood, Maureen Naylor, Julie Croft, Katherine Farley, Deborah D Stocken, David G Jayne

Colorectal Disease · 2024-12 · 26 (12) · 2101-2111

DOI: 10.1111/codi.17194 ↗

At a glance

Randomisierte kontrollierte Studie in Colorectal Disease, published online on 2024-10-12. Written by Stephen J Chapman and 8 co-authors. Institution: Leeds Institute of Medical Research, University of Leeds, Leeds, UK. Major MEDLINE topics: Feasibility Studies, Ileus, Postoperative Complications, Vagus Nerve Stimulation. Cited 5 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institute for Health and Care Research.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Aim

Ileus is characterized by a period of intestinal dysmotility after surgery, leading to vomiting and constipation. In preclinical models, vagus nerve stimulation reduces intestinal inflammation and prevents smooth muscle dysfunction, accelerating the return of gut function. This study explored the feasibility of a definitive trial of non‐invasive vagus nerve stimulation (nVNS) along with an early assessment of efficacy.

Method

A multicentre, randomized feasibility trial (IDEAL Stage 2B) of self‐administered nVNS was performed. Patients undergoing colorectal surgery were randomized to nVNS or sham before and after surgery. Feasibility outcomes comprised assessments of recruitment, compliance, blinding and attrition. Clinical outcomes were measures of intestinal function and adverse events. All participants were followed up for 30 days. Interviews with patients and health professionals explored barriers to feasibility and perspectives around implementation.

Results

In all, 125 patients were approached about the study and 97 (77.6%) took part. Across all randomized groups, the median compliance to treatment was 19 out of 20 stimulations (interquartile range 17–20). The incidence of adverse events was similar across groups. In this unpowered feasibility study, the time taken for the return of gut function (such as first passage of stool) was similar between nVNS and sham treatments. According to interviews, patients were highly motivated to use the device because it provided them with an opportunity to engage actively in their care. Health professionals were highly driven to tackle the problem of ileus.

Conclusion

Powered assessments of clinical efficacy are required to confirm or refute the promise of nVNS, as already demonstrated in preclinical models. This feasibility study concludes that a definitive randomized assessment of the clinical benefits of nVNS is desired and feasible.

Subjects

MeSH terms (MEDLINE)

Feasibility StudiesIleusPostoperative ComplicationsVagus Nerve StimulationHumansFemaleMaleMiddle AgedAgedTreatment OutcomeColorectal Surgery

Author keywords

clinical trialsgastrointestinal surgeryintestinal motilitynerve–gut interactions

Authors and institutions

  • Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • West Yorkshire Ileostomy Association, UK.
  • Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

ORCID profiles: Stephen J Chapman

Funding

  • National Institute for Health and Care Research

Cite

APA

Chapman, S. J., Kowal, M., Helliwell, J. A., Lockwood, S., Naylor, M., Croft, J., Farley, K., Stocken, D. D., & Jayne, D. G. (2024). Non‐invasive vagus nerve stimulation to reduce ileus after colorectal surgery: randomized feasibility trial and efficacy assessment ( IDEAL Stage 2B ). Colorectal Disease, 26(12), 2101-2111. https://doi.org/10.1111/codi.17194

Vancouver

Chapman SJ, Kowal M, Helliwell JA, Lockwood S, Naylor M, Croft J, et al. Non‐invasive vagus nerve stimulation to reduce ileus after colorectal surgery: randomized feasibility trial and efficacy assessment ( IDEAL Stage 2B ). Colorectal Disease. 2024;26(12):2101-2111. doi:10.1111/codi.17194

BibTeX
@article{Chapman2024,
  author = {Chapman, Stephen J and Kowal, Mikolaj and Helliwell, Jack A and Lockwood, Sonia and Naylor, Maureen and Croft, Julie and Farley, Katherine and Stocken, Deborah D and Jayne, David G},
  title = {Non‐invasive vagus nerve stimulation to reduce ileus after colorectal surgery: randomized feasibility trial and efficacy assessment ( IDEAL Stage 2B )},
  journal = {Colorectal Disease},
  year = {2024},
  volume = {26},
  number = {12},
  pages = {2101--2111},
  doi = {10.1111/codi.17194}
}
Start for free →